No Data
No Data
No Data
No Data
No Data
Express News | Shanghai Yizhong: Net profit of 29.178 million yuan in the first quarter decreased by 46.97% year on year
BreakingsApr 29 19:38
A-share innovative drug concept stocks declined, Kain Technology fell more than 17%
Gelonghui, April 10 | Kain Technology fell more than 17%, followed by Shanghai Yizhong, Pharmaceutical Kangchen, and Sailong Pharmaceutical.
Gelonghui FinanceApr 10 09:42
Shanghai Yizhong (688091.SH) Performance Report: Net profit of 2023 was 163 million yuan, up 13.78% year-on-year
Gelonghui, Feb. 26: Shanghai Yizhong (688091.SH) announced the 2023 Annual Results Report. The company achieved operating revenue of 360 million yuan in 2023, an increase of 52.68% over the previous year. Net profit attributable to owners of the parent company was 163 million yuan, up 13.78% from the previous year; net profit attributable to owners of the parent company after deducting non-recurring profit and loss was 162 million yuan, an increase of 57.66% over the previous year.
Gelonghui FinanceFeb 26 17:57
Yizhong Pharmaceutical Starts Construction of Paclitaxel Polymer Micelles Production Facility; Shares Down 3%
Shanghai Yizhong Pharmaceutical (SHA:688091) started building a facility producing paclitaxel polymer micelles for injection after obtaining a construction license from the local government of China's
MT NewswiresFeb 5 14:38
Express News | Shanghai Yizhong: Fund-raising Project Obtains Construction Permit for Construction Projects
BreakingsFeb 4 16:11
Shanghai Yizhong (688091.SH): “Construction of 5 million injectable paclitaxel polymer micelles and supporting facilities per year” has obtained a construction license for construction projects
Gelonghui, Feb. 4: Shanghai Yizhong (688091.SH) announced that it has recently obtained a “Construction Permit” issued by the Fengxian District Construction and Management Committee, marking that the “construction of 5 million injectable paclitaxel polymer micelles and supporting facilities per year” has entered the construction phase.
Gelonghui FinanceFeb 4 15:39
No Data
No Data